Literature DB >> 9344838

On the regulation and function of human polo-like kinase 1 (PLK1): effects of overexpression on cell cycle progression.

K E Mundt1, R M Golsteyn, H A Lane, E A Nigg.   

Abstract

The human protein kinase Plk1, a member of the polo-like kinase family, is known to function at mitosis. Here we show that the relative specific activity of Plk1 increases in mitosis, that Plk1 is specifically phosphorylated during mitosis, and that phosphatase treatment reduces mitotic Plk1 activity to interphase levels. To identify domains involved in the regulation of Plk1 activity, deletion mutants of Plk1 were constructed and their activities examined. Deletion of the extreme C-terminus of Plk1 substantially increased kinase activity, indicating that the C-terminus harbors an inhibitory domain. Finally, the consequences of over-production of wild-type and mutant Plk1 protein were analyzed, using transient transfection assays. Cells overexpressing Plk1 protein were able to enter mitosis and establish an apparently normal bipolar spindle. In contrast, progression through mitosis was transiently delayed, and cytokinesis appeared to be disturbed, as reflected by a significant increase in large cells with multiple, often fragmented nuclei. These results are relevant to recently proposed roles for Plks during both entry into and exit from mitosis. Copyright 1997 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9344838     DOI: 10.1006/bbrc.1997.7378

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  77 in total

1.  Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells.

Authors:  Patrick Meraldi; Reiko Honda; Erich A Nigg
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

2.  Plk1 regulates activation of the anaphase promoting complex by phosphorylating and triggering SCFbetaTrCP-dependent destruction of the APC Inhibitor Emi1.

Authors:  David V Hansen; Alexander V Loktev; Kenneth H Ban; Peter K Jackson
Journal:  Mol Biol Cell       Date:  2004-10-06       Impact factor: 4.138

Review 3.  Understanding cytokinesis failure.

Authors:  Guillaume Normand; Randall W King
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

4.  Polo-like kinase is required for the fragmentation of pericentriolar Golgi stacks during mitosis.

Authors:  C Sütterlin; C Y Lin; Y Feng; D K Ferris; R L Erikson; V Malhotra
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

5.  Use of the novel Plk1 inhibitor ZK-thiazolidinone to elucidate functions of Plk1 in early and late stages of mitosis.

Authors:  Anna Santamaria; Rüdiger Neef; Uwe Eberspächer; Knut Eis; Manfred Husemann; Dominik Mumberg; Stefan Prechtl; Volker Schulze; Gerhard Siemeister; Lars Wortmann; Francis A Barr; Erich A Nigg
Journal:  Mol Biol Cell       Date:  2007-08-01       Impact factor: 4.138

6.  The dual-specificity phosphatase CDC14B bundles and stabilizes microtubules.

Authors:  Hyekyung P Cho; Yie Liu; Marla Gomez; John Dunlap; Mike Tyers; Yisong Wang
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

7.  Plk phosphorylation regulates the microtubule-stabilizing protein TCTP.

Authors:  Frederic R Yarm
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

8.  The crystal structure of the human polo-like kinase-1 polo box domain and its phospho-peptide complex.

Authors:  Kin-Yip Cheng; Edward D Lowe; John Sinclair; Erich A Nigg; Louise N Johnson
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

9.  Phase I study of ON 01910.Na, a novel modulator of the Polo-like kinase 1 pathway, in adult patients with solid tumors.

Authors:  Antonio Jimeno; Jing Li; Wells A Messersmith; Daniel Laheru; Michelle A Rudek; Manoj Maniar; Manuel Hidalgo; Sharyn D Baker; Ross C Donehower
Journal:  J Clin Oncol       Date:  2008-10-27       Impact factor: 44.544

10.  Association of mitotic regulation pathway polymorphisms with pancreatic cancer risk and outcome.

Authors:  Fergus J Couch; Xianshu Wang; William R Bamlet; Mariza de Andrade; Gloria M Petersen; Robert R McWilliams
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-01       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.